2-(4-(PIPERIDIN-4-YLOXY)PHENYL)ACETAMIDE, 95.0%, 250mg

5-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 250mg

1-[2-(hydroxymethyl)phenyl]ethan-1-ol, 95+%, 250mg

5,6-Dichloro-2,3-dicyanopyrazine, 98.0%, 1g

Éster n-butílico del ácido acético, 1 l

2-(Trifluoroacetyl)pyrrole, 98.0%, 10g

MONODICARBINOL TERMINATED POLYDIMETHYLSILOXANE, asymmetric, 50-60cSt, 100g

3-oxo-N-(1-phenylethyl)butanamide, 95.0%, 5g

Matraz de fondo redondo de cuatro bocas Bocas paralelas, 5000 ml, 45/40, 1 unidad

4,7-Dibromo-5,6-bis(dodecyloxy)-2,1,3-benzothiadiazole>98.0%(HPLC)200mg

2,5-Dichlorobenzyl Bromide>98.0%(GC)5g

(S)-(4-(Prop-1-en-2-yl)cyclohex-1-en-1-yl)methanol, 95.0%, 10g

tert-Butyl 4-(4-methoxybenzoyl)piperidine-1-carboxylate, 95%, 5g